
Bayer Suspends Essure Sterilizing Birth-Control Implant From Foreign Markets
But it is business as usual in the U.S. for the device plagued by lawsuits and allegations of harm.
But it is business as usual in the U.S. for the device plagued by lawsuits and allegations of harm.
Subscriber Service CenterAlready a subscriber? Renew or manage your subscription here.
Subscribe for just $49.95 $32.50!Start your Register subscription today.
Give a Gift SubscriptionBless friends, family or clergy with a gift of the Register.
Order NowOrder Bulk SubscriptionsGet a discount on 6 or more copies sent to your parish, organization or school.
Order NowSign-up for E-NewsletterGet Register Updates sent daily or weeklyto your inbox.
Sign Up